OGEN News and Press, Oragenics Inc. From 04/15/20

Oragenics, Inc. (NYSE American: OGEN) , a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced today that early top-line results of the company’s Phase 2 clinical trial of AG013 in oral mucositis in chemoradi...

Are These Penny Stocks On Your List This Week? With the rise of coronavirus penny stocks , speculation is driving the market right now. The key focus for novice traders is scoring a quick buck. However, emotion is a curse and a blessing especially when it comes to trading penny stocks . Fear...

Are These Penny Stocks On Your Watch List? Are you looking for penny stocks to buy ? Or maybe you’re simply looking to learn about some trending penny stocks to watch right now. No matter what camp you’re in, you’ve come to the right place. We’ve built a track reco...

Do These Make The Cut Of Penny Stocks To Buy Right Now? Penny stocks usually trade below $5, but there are other penny stocks that might be trading at even lower levels. It is possible for investors to find value from among those stocks as well but you need a good eye for quality penny stoc...

Oragenics, Inc. (NYSE American: OGEN) , a leader in the development of effective treatments for oral mucositis and new antibiotics against infectious diseases, announced today that Alan Joslyn, Ph.D., president and CEO of Oragenics, Inc., will present a corporate overview at the 22 nd Ann...

Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announced that Alan Joslyn, Ph.D., president and CEO of Oragenics, Inc. will be a featured presenter at the LD Micro Main Event ...

Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (OM), today announced the completion of enrollment in its ongoing double-blind, randomized, placebo-controlled Phase 2 trial of its lea...

These Penny Stocks Trade For Less Than A Cup Of Coffee But Are They Worth Your Time? One of the main attractions of penny stocks is the fact that they are cheap. But they also have the potential of generating enormous returns if the company grows. Penny stocks generally trade below $5, but...

Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (“OM”), today announces the publication of the outcome of the a specific chemical synthesis of the bicyclic C/D ring of a...

Clinical Differentiation And Gap Oragenics Inc. ( OGEN ) is a small-cap ($21M) clinical-stage company developing innovative therapies for SOM and infectious diseases. Focusing on SOM associated with head and neck cancer (HNC.) radiotherapy, Phase 2 investigative drug candidate AGO13 was i...